KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Shares Outstanding (2016 - 2025)

Biogen (BIIB) has 11 years of Shares Outstanding data on record, last reported at $23.8 million in Q4 2022.

  • For Q4 2022, Shares Outstanding changed 0.0% year-over-year to $23.8 million; the TTM value through Dec 2022 reached $23.8 million, changed 0.0%, while the annual FY2022 figure was $23.8 million, 0.0% changed from the prior year.
  • Shares Outstanding reached $167.9 million in Q4 2022 per BIIB's latest filing, down from $170.8 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $225.2 million in Q2 2018 and bottomed at $23.8 million in Q1 2018.
  • Average Shares Outstanding over 5 years is $141.5 million, with a median of $170.8 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: plummeted 89.89% in 2018, then increased 3.79% in 2019.
  • A 5-year view of Shares Outstanding shows it stood at $23.8 million in 2018, then changed by 0.0% to $23.8 million in 2019, then changed by 0.0% to $23.8 million in 2020, then changed by 0.0% to $23.8 million in 2021, then changed by 0.0% to $23.8 million in 2022.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $23.8 million in Q4 2022, $23.8 million in Q4 2021, and $23.8 million in Q4 2020.